EGFR and cancer: Both BET PROTACs MZ1 and ARV-771 were able to downregulate all ERBB family receptors in MDA-MB-231, which play key roles in activating the Mitogen-Activated Protein Kinase (MAPK) pathway and are connected to the development of many types of cancer [32].